282 related articles for article (PubMed ID: 6778861)
1. Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase.
Vermilion JL; Ballou DP; Massey V; Coon MJ
J Biol Chem; 1981 Jan; 256(1):266-77. PubMed ID: 6778861
[TBL] [Abstract][Full Text] [Related]
2. Oxidation-reduction states of FMN and FAD in NADPH-cytochrome P-450 reductase during reduction by NADPH.
Oprian DD; Coon MJ
J Biol Chem; 1982 Aug; 257(15):8935-44. PubMed ID: 6807985
[TBL] [Abstract][Full Text] [Related]
3. Studies on the microsomal mixed-function oxidase system: mechanism of action of hepatic NADPH-cytochrome P-450 reductase.
Iyanagi T; Makino R; Anan FK
Biochemistry; 1981 Mar; 20(7):1722-30. PubMed ID: 6784758
[TBL] [Abstract][Full Text] [Related]
4. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
[TBL] [Abstract][Full Text] [Related]
5. Flavins of NADPH-cytochrome P-450 reductase: evidence for structural alteration of flavins in their one-electron-reduced semiquinone states from resonance Raman spectroscopy.
Sugiyama T; Nisimoto Y; Mason HS; Loehr TM
Biochemistry; 1985 Jun; 24(12):3012-9. PubMed ID: 3925989
[TBL] [Abstract][Full Text] [Related]
6. Quantitation of FAD-dependent cytochrome P450 reductase activity by photoreduction.
Hodgson AV; Strobel HW
Anal Biochem; 1996 Dec; 243(1):154-7. PubMed ID: 8954538
[TBL] [Abstract][Full Text] [Related]
7. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
Bonants PJ; Müller F; Vervoort J; Edmondson DE
Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
[TBL] [Abstract][Full Text] [Related]
8. Interflavin one-electron transfer in the inducible nitric oxide synthase reductase domain and NADPH-cytochrome P450 reductase.
Yamamoto K; Kimura S; Shiro Y; Iyanagi T
Arch Biochem Biophys; 2005 Aug; 440(1):65-78. PubMed ID: 16009330
[TBL] [Abstract][Full Text] [Related]
9. The flavoprotein domain of P450BM-3: expression, purification, and properties of the flavin adenine dinucleotide- and flavin mononucleotide-binding subdomains.
Sevrioukova I; Truan G; Peterson JA
Biochemistry; 1996 Jun; 35(23):7528-35. PubMed ID: 8652532
[TBL] [Abstract][Full Text] [Related]
10. Stopped-flow kinetic studies of flavin reduction in human cytochrome P450 reductase and its component domains.
Gutierrez A; Lian LY; Wolf CR; Scrutton NS; Roberts GC
Biochemistry; 2001 Feb; 40(7):1964-75. PubMed ID: 11329263
[TBL] [Abstract][Full Text] [Related]
11. Determination of the redox properties of human NADPH-cytochrome P450 reductase.
Munro AW; Noble MA; Robledo L; Daff SN; Chapman SK
Biochemistry; 2001 Feb; 40(7):1956-63. PubMed ID: 11329262
[TBL] [Abstract][Full Text] [Related]
12. Studies on FAD- and FMN-binding domains in NADPH-cytochrome P-450 reductase from rabbit liver microsomes.
Nisimoto Y; Shibata Y
J Biol Chem; 1982 Nov; 257(21):12532-9. PubMed ID: 6813323
[TBL] [Abstract][Full Text] [Related]
13. NADPH-cytochrome P-450 reductase. Physical properties and redox behavior in the absence of the FAD moiety.
Kurzban GP; Howarth J; Palmer G; Strobel HW
J Biol Chem; 1990 Jul; 265(21):12272-9. PubMed ID: 2115516
[TBL] [Abstract][Full Text] [Related]
14. Electron transfer in flavocytochrome P450 BM3: kinetics of flavin reduction and oxidation, the role of cysteine 999, and relationships with mammalian cytochrome P450 reductase.
Roitel O; Scrutton NS; Munro AW
Biochemistry; 2003 Sep; 42(36):10809-21. PubMed ID: 12962506
[TBL] [Abstract][Full Text] [Related]
15. Blue light mediated photoreduction of the flavoprotein NADPH-cytochrome P450 reductase. A Förster-type energy transfer.
Müller-Enoch D
Z Naturforsch C J Biosci; 1997; 52(9-10):605-14. PubMed ID: 9373993
[TBL] [Abstract][Full Text] [Related]
16. The flavoprotein component of the Escherichia coli sulfite reductase: expression, purification, and spectral and catalytic properties of a monomeric form containing both the flavin adenine dinucleotide and the flavin mononucleotide cofactors.
Zeghouf M; Fontecave M; Macherel D; Covès J
Biochemistry; 1998 Apr; 37(17):6114-23. PubMed ID: 9558350
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of a 5'-deazaFAD T491V NADPH-cytochrome P450 reductase.
Zhang H; Gruenke L; Saribas AS; Im SC; Shen AL; Kasper CB; Waskell L
Biochemistry; 2003 Jun; 42(22):6804-13. PubMed ID: 12779335
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the oxidation of hydroxyl radical scavenging agents after alkaline phosphatase treatment of rat liver microsomes.
Puntarulo S; Cederbaum AI
Biochim Biophys Acta; 1991 May; 1074(1):12-8. PubMed ID: 1904277
[TBL] [Abstract][Full Text] [Related]
19. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
Murataliev MB; Klein M; Fulco A; Feyereisen R
Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
[TBL] [Abstract][Full Text] [Related]
20. The FMN-binding domain of cytochrome P450BM-3: resolution, reconstitution, and flavin analogue substitution.
Haines DC; Sevrioukova IF; Peterson JA
Biochemistry; 2000 Aug; 39(31):9419-29. PubMed ID: 10924137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
